Menck K, Wlochowitz D, Wachter A, Conradi LC, Wolff A, Scheel AH, Korf U, Wiemann S, Schildhaus HU, Bohnenberger H, Wingender E, Pukrop T, Homayounfar K, Beißbarth T, Bleckmann A.High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.Cancers (Basel). 2022 Apr 21;14(9):2084.
Menck K, Heinrichs S, Wlochowitz D, Sitte M, Noeding H, Janshoff A, Treiber H, Ruhwedel T, Schatlo B, von der Brelie C, Wiemann S, Pukrop T, Beißbarth T, Binder C, Bleckmann A.WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer.J Exp Clin Cancer Res. 2021 Dec 15;40(1):395.
Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A.Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.Oncotarget. 2021 Sep 14;12(19):1946-1952.
Menck K, Heinrichs S, Baden C, Bleckmann A. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention. Cells. 2021 Jan 12;10(1): 142.
Menck K, Sivaloganathan S, Bleckmann A, Binder C. Microvesicles in Cancer: Small, Large, Potential.. Int J Mol Sci. 2020 Jul 28;21(15): 5373, doi: 10.3390/ijms21155373.
Fromme JE, Schmitz K, Wachter A, Grzelinski M, Zielinski D, Koppel C, Conradi LC, Homayounfar K, Hugo T, Hugo S, Lukat L, Rüschoff J, Ströbel P, Ghadimi M, Beißbarth T, Reuter-Jessen K, Schildhaus HU, Bleckmann A. FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis. Oncotarget. 2018 Aug 14;9(63): 32204-32218.
Menck K, Sönmezer C, Worst TS, Schulz M, Dihazi GH, Streit F, Erdmann G, Kling S, Boutros M, Binder C, Gross JC. Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane.J Extracell Vesicles. 2017 Sep 26; 6(1): 1378056. doi: 10.1080/20013078.2017.1378056. eCollection 2017.
Menck K, Bleckmann A, Wachter A, Hennies B, Ries L, Schulz M, Balkenhol M, Pukrop T, Schatlo B, Rost U, Wenzel D, Klemm F, Binder C. Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome.J Extracell Vesicles. 2017 Jul 16; 6(1): 1340745.
Bayerlová M, Menck K, Klemm F, Wolff A, Pukrop T, Binder C, Beißbarth T, Bleckmann A. Ror2 Signaling and Its Relevance in Breast Cancer Progression.Front Oncol. 2017 Jun 26; 7:135. doi: 10.3389/fonc.2017.00135. eCollection 2017.
Bleckmann A, Conradi LC, Menck K, Schmick NA, Schubert A, Rietkötter E, Arackal J, Middel P, Schambony A, Liersch T, Homayounfar K, Beißbarth T, Klemm F, Binder C, Pukrop T. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Clin Exp Metastasis. 2016 Apr; 33(4): 309-23. doi: 10.1007/s10585-016-9780-3. Epub 2016 Feb 9.
Menck K, Wlochowitz D, Wachter A, Conradi LC, Wolff A, Scheel AH, Korf U, Wiemann S, Schildhaus HU, Bohnenberger H, Wingender E, Pukrop T, Homayounfar K, Beißbarth T, Bleckmann A.High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.Cancers (Basel). 2022 Apr 21;14(9):2084.
Menck K, Heinrichs S, Wlochowitz D, Sitte M, Noeding H, Janshoff A, Treiber H, Ruhwedel T, Schatlo B, von der Brelie C, Wiemann S, Pukrop T, Beißbarth T, Binder C, Bleckmann A.WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer.J Exp Clin Cancer Res. 2021 Dec 15;40(1):395.
Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A.Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.Oncotarget. 2021 Sep 14;12(19):1946-1952.
Menck K, Heinrichs S, Baden C, Bleckmann A. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention. Cells. 2021 Jan 12;10(1): 142.
Menck K, Sivaloganathan S, Bleckmann A, Binder C. Microvesicles in Cancer: Small, Large, Potential.. Int J Mol Sci. 2020 Jul 28;21(15): 5373, doi: 10.3390/ijms21155373.
Fromme JE, Schmitz K, Wachter A, Grzelinski M, Zielinski D, Koppel C, Conradi LC, Homayounfar K, Hugo T, Hugo S, Lukat L, Rüschoff J, Ströbel P, Ghadimi M, Beißbarth T, Reuter-Jessen K, Schildhaus HU, Bleckmann A. FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis. Oncotarget. 2018 Aug 14;9(63): 32204-32218.
Menck K, Sönmezer C, Worst TS, Schulz M, Dihazi GH, Streit F, Erdmann G, Kling S, Boutros M, Binder C, Gross JC. Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane.J Extracell Vesicles. 2017 Sep 26; 6(1): 1378056. doi: 10.1080/20013078.2017.1378056. eCollection 2017.
Menck K, Bleckmann A, Wachter A, Hennies B, Ries L, Schulz M, Balkenhol M, Pukrop T, Schatlo B, Rost U, Wenzel D, Klemm F, Binder C. Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome.J Extracell Vesicles. 2017 Jul 16; 6(1): 1340745.
Bayerlová M, Menck K, Klemm F, Wolff A, Pukrop T, Binder C, Beißbarth T, Bleckmann A. Ror2 Signaling and Its Relevance in Breast Cancer Progression.Front Oncol. 2017 Jun 26; 7:135. doi: 10.3389/fonc.2017.00135. eCollection 2017.
Bleckmann A, Conradi LC, Menck K, Schmick NA, Schubert A, Rietkötter E, Arackal J, Middel P, Schambony A, Liersch T, Homayounfar K, Beißbarth T, Klemm F, Binder C, Pukrop T. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Clin Exp Metastasis. 2016 Apr; 33(4): 309-23. doi: 10.1007/s10585-016-9780-3. Epub 2016 Feb 9.